Background: Little has been known about clinical features and prognosis of very old patients with heart failure with preserved ejection fraction (HFPEF). The aim of this study was to compare clinical features and clinical outcomes between HFPEF and heart failure with reduced ejection fraction (HFREF) in patients older than 80 years. Methods: We enrolled a total of 113 patients over 80 years old, who were admitted for heart failure between 2006 and 2009. We retrospectively analyzed the clinical features including laboratory data and echocardiography parameters. Results: In 53 patients (49%) left ventricular ejection fraction was preserved. The clinical characteristics and treatment between HFPEF and HFREF showed that anemia was one of the risk factors for HFPEF, and the long-term outcomes of HFPEF in this population were not different from that of HFREF. Conclusion: These results suggest that anemia is one of the important risk factors for HFPEF in the very elderly.
Introduction
Heart failure is a common problem in elderly people. In the elderly population, heart failure with preserved ejection fraction (HFPEF) has been increasingly recognized. Previous reports suggested that the rate of HFPEF was up to 30-50% 0914-5087/$ -see front matter © 2011 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved. doi:10.1016/j.jjcc.2011. 11.014 of all patients with heart failure and the rate of HFPEF increases according to age [1, 2] . HFPEF is accompanied by hypertension, diabetes mellitus, and atrial fibrillation, while heart failure with reduced ejection fraction (HFREF) is often accompanied by ischemic heart disease and dilated cardiomyopathy [3] [4] [5] [6] . However little is known about clinical features and prognosis of HEPEF in very old patients. Moreover, it is not known whether the long-term outcome with HFPEF is different from that with HFREF in very elderly people. The aim of this study was to compare clinical features and clinical outcomes between HFPEF and HFREF in patients older than 80 years.
Methods

Patient population
Between 2006 and 2009, there were 511 patients admitted for the treatment of heart failure in our hospital. The definition of heart failure followed the Framingham criteria. Among these 511 patients, we included patients over 80 years old whose echocardiography was available and EF was confirmed by echocardiography.
Eligible patients were those hospitalized for worsening heart failure as the primary cause of admission. For each patient, baseline data obtained at discharge included the following demographic parameters: cause of heart failure, precipitating cause, comorbidities, complications, clinical status, electrocardiographic and echocardiographic findings, plasma brain-type natriuretic peptide (BNP), and treatment including discharge medications. Heart failure due to acute myocardial infarction was excluded. Heart failure due to valve heart disease such as mitral regurgitation or constrictive pericarditis was not excluded.
Patients and follow-up
We retrospectively analyzed the clinical features including laboratory data and echocardiography parameters. Followup was performed via last office visit of medical records.
Definition of other clinical criteria
Definitions of the clinical criteria were defined as follows: hypertension, systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg, or medical treatment for hypertension before admission; hyperlipidemia, cholesterol level >220 mg/dl or treatment for hyperlipidemia before admission; diabetes mellitus, hemoglobin A1c level >6.5% or treatment for diabetes mellitus before admission. Anemia was defined as hemoglobin concentration (<12 g/dl in males or <11 g/dl in females) [7] . The presence of atrial fibrillation, and the background disease or etiology of heart failure, were examined from the medical records. The medication data were adopted at the time of first discharge. Estimated glomerular filtration rate (eGFR) was calculated according to the Cockroft-Gault formula [8] . EF 50% EF<50% Figure 1 Flow chart of patient selection. CHF, chronic heart failure; EF, ejection fraction; MR, mitral regurgitation; HFPEF, heart failure with preserved ejection fraction; HFREF, heart failure with reduced ejection fraction.
Echocardiography
Echocardiography was obtained by using commercially available ultrasound systems (SSA-380A, Toshiba, Tokyo, Japan or SONOS-7500, Phillips, Atlanta, GA, USA). EF was calculated by Teichholz method. Echocardiography was performed within one week from hospital admission. HFPEF was defined as EF ≥50% and HFREF as EF <50%. 
Statistical analysis
Results
There were 511 patients who were admitted to our hospital for the treatment of chronic heart failure (CHF) between 2006 and 2009 ( Fig. 1) . Among 511 patients, 128 patients were over 80 years old. In these 128 patients, 15 patients (12%) had moderate-to-severe mitral regurgitation or aortic stenosis and constrictive pericarditis and they were excluded. The remaining 113 patients whose echocardiography was available and EF was confirmed by echocardiography were analyzed in this study. Among these 113 patients, there were 55 with HFPEF (49%) and 58 with HFREF (51%) (Fig. 1) . Table 1 shows the clinical characteristics and medication of the two groups. Ischemic heart disease (IHD) as background disease was more frequent in HFREF. The level of BNP was significantly higher in HFREF than HFPEF. Calciumchannel blockers were more frequently prescribed in HFPEF. Left ventricle wall was thicker in HFPEF. The level of hemoglobin was lower in HFPEF than HFREF. Anemia was more frequent in HFPEF. The results of logistic multivariate analysis for the parameters which were significant (p < 0.05) in multivariate analysis (IHD, calcium-channel blocker, BNP, Mean ± SD, number (%). HFPEF, heart failure with preserved ejection fraction; HFREF, heart failure with reduced ejection fraction; Dd, diastolic dimension; Ds, systolic dimension; IVST, intraventricular septum thickness; PWT, posterior wall thickness.
and anemia) showed that anemia was independently associated with HFPEF in the elderly (p = 0.02, odds ratio = 3.11, 95% confidence interval: 01.24-7.80) ( Table 2 ). The Kaplan-Meyer curves of all-cause death, cardiovascular death, and heart failure-related re-hospitalization between HFPEF and HFREF are shown in Fig. 2 . The mean follow-up period was 266 ± 358 days (mean ± SD). There was no difference in all-cause mortality, cardiovascular death, and heart failure-related re-hospitalization between HFPEF and HFREF.
Discussion
Our study has showed that the 49% of CHF cases in the elderly were HFPEF. In our study, anemia was associated with HFPEF. The all-cause death, cardiovascular death, and re-hospitalization were not different between HFPEF and HFREF in the very elderly.
Previous reports showed that the frequency of HFPEF was 30-50% among CHF in overall-age population [1] [2] [3] 5] increasing with age [9] . This study showed that 49% of CHF patients in the elderly were HFPEF, which is in line with the previous studies. Age [6, 10] , female gender [5, 6, 10] , hypertension [1, 6, [10] [11] [12] , diabetes mellitus [3, 6] , atrial fibrillation [3, 6] , use of calcium-channel blockers [13, 14] or digoxin, and left ventricular hypertrophy [5] , are reported to be associated with HFPEF. IHD [4] , dyslipidemia, statin use [13] , and a higher level of hemoglobin [13] are also reported to be associated with HFREF. In our study with the very elderly patients, calcium-channel blockers were more frequently prescribed, and left ventricular hypertrophy was more often observed in HFPEF, which was in agreement with previous reports on HEPEF [3, 5, 13, 15] . In our study, the frequencies of female sex, hypertension, diabetes mellitus, atrial fibrillation, are not significantly different between HFPEF and HFPRF. Anemia has been reported as a risk factor for HFPEF in a previous report [16] , which was also consistent with this present study. Aging is a strong determinant of prognosis, and prevalence of other systemic diseases such as malignancy or renal dysfunction increase with age [17] . Renal dysfunction also might lead to the decreased production of endogenous erythropoietin and might ultimately induce anemia. In our study, however, the renal function was not significantly different between HFPEF and HFREF. A previous study reports that the frequency of malignancy was significantly higher in HFPEF than HFREF [14] . The existence of malignancy may have to be sought in cases with HFPEF in the elderly population especially in anemic patients. In this retrospective analysis, the cause of anemia was not determined.
There are conflicting reports regarding the long-term outcomes of HFPEF. Some have shown similar event rates between HFPEF or HFREF [1, 5, 13] , while others have shown better event rates in HFPEF [2, 3, 18] . In our study on the very elderly, the all-cause death, cardiac death, and heart failure-related re-hospitalization were not significantly different between the two groups. However, a large number of non-cardiac deaths such as malignant tumor, pneumonia, and stroke can confound the results in the elderly population. Our results suggest that the prognosis of HFPEF was as poor as HFREF in the very elderly; however, this should be confirmed in a larger population.
Study limitations
First, a retrospective study design with a relatively small sample size in a single center would pose a risk for patient selection bias. Second, documentation of biochemistry data at hospital discharge might not accurately reflect the level after discharge or changes over time. Third, echocardiography data were obtained by the Teicholz method, which may not accurately reflect the actual EF in some patients.
Conclusions
Our study has shown that nearly half of the CHF patients over 80 years of age had HFPEF. Anemia was one of the risk factors for HFPEF, and the long-term outcomes of HFPEF in this population were not different from that of HFREF.
